Dunn Edmund 4
4 · Monte Rosa Therapeutics, Inc. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Dunn Edmund
Principal Accounting Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-02+35,900→ 35,900 totalExercise: $5.71Exp: 2034-01-01→ Common Stock (35,900 underlying) - Award
Stock Option (Right to Buy)
2024-01-02+25,000→ 25,000 totalExercise: $5.71Exp: 2034-01-01→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]25% of this option shall vest and become exercisable on October 2, 2024, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
- [F2]25% of this option shall vest and become exercisable on January 1, 2025, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.